Der Antik?rper-Klon SZ31 reagiert als erster Antik?rper spezifisch mit CD31 in standardm?ssig Formalin-fixierten Paraffin-eingebetteten (FFPE) Mausgeweben. Klon SZ31 zeigt keine Kreureaktion mit humanem CD31.
Die überragende Spezifit?t von Klon SZ31 wird in mehr als 175 Publikationen (CiteAb) best?tigt.
Background:
CD31, auch bekannt als PECAM-1 (Platelet Endothelial Cell Adhesion Molecule-1), wird auf der Oberfl?che embryonaler und adulter Endothelzellen konstitutiv exprimiert. Sowie auf Zelloberfl?chen von Monozyten, Neutrophilen, Thrombozyten und verschiedener Untergruppen der T-Zellen. Zudem konnte das Molekül auf h?matopoetischen Stammzellen aus dem Knochenmark und embryonalen Stammzellen nachgewiesen werden. Cluster of Differentiation 31 (CD31) ist ein integrales Membranglykoprotein (130 kDa), welches als Mitglied der Immunglobulin-Superfamilie an der Vermittlung der Zell-Zell-Adh?sion beteiligt ist. Die von CD31 vermittelte endotheliale Zell-Zell-Interaktion, spielt hierbei eine entscheidende Rolle in der Angiogenese. Das Adh?sionsmolekül gilt als einer der wichtigsten Marker in der humanen Angiogenese, Studien zufolge kann der Nachweis von CD31 auf ein Tumorrezidiv deuten. Pathophysiologische Untersuchungen von CD31 in Maus-Modellsystemen waren bisher nur begrenzt m?glich, weil Standard-FFPE Gewebe ausgeschlossen werden mussten. Der Ratten-Klon SZ31 (Anti-CD31) l?st diese Probleme. Unser monoklonaler Antik?rper erlaubt erstmalsimmunhistochemische Analysen von CD31 in Formalin-fixierten Paraffingeweben (FFPE) der Maus und überzeugt durch beeindruckende Qualit?t der mikroskopischen Aufnahmen.
Immunhistochemischer Nachweis von Maus-CD31 (PECAM-1) in Formalin-fixierten, Paraffin-eingebetteten Gewebeschnitten
Der monoklonale Antik?rper Klon SZ31 reagiert spezifisch mit Endothelzellen in Gef??en und Kapillaren von:
aorta
aortic origin
endocardium
small intestine
small intestine
colon
brain
lymph nodes
bone marrow
mesenterial vessels
kidney
pancreas
(Bilder mit freundlicher Genehmigung von Prof. Dr. Robert Klopfleisch, Institute of Pathology, Department of Veterinary Pathology, Berlin)
Lung
Muscle
Spinal
Liver
Adenocarcinoma
Adenocarcinoma
(Bilder mit freundlicher Genehmigung von Prof. Dr. H. Stein, Institute of Pathology, Charité Campus Benjamin Franklin, Berlin)
Western Blot-Analyse
Immunoblot mit Zellextrakten aus Mauslunge, J558L Zellen und m-Lend Zellen. Antik?rper-Klon SZ31 (DIA-310 1:500) wurde zusammen mit einem Ziege Anti-Ratte-HRP Sekund?rantik?rper (1:10.000) zum Nachweis von CD31 verwendet.
Spur:
J558 Zellen (CD31-), 25μg Lysat
Mauslunge, 25μg Lysat
blank
m-Lend Zellen (CD31+), 12.5μg Lysat
Specific References:
Kim K, Watson PA, Lebdai S, Jebiwott S, Somma A, La Rosa SP, Mehta D, Murray KS, Lilja HG, Ulmert D, Monette S, Scherz AJ, Coleman J. Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts. Clin Cancer Res. 2018 Feb 20; PMID: 29463549
de Jong RJ, Paulin N, Lemnitzer P, Viola JR, Winter C, Ferraro B, Grommes J, Weber C, Reutelingsperger C, Drechsler M, Soehnlein O. Protective Aptitude of Annexin A1 in Arterial Neointima Formation in Atherosclerosis-Prone Mice-Brief Report. Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):312–315. PMID: 28062503
Looney AP, Han R, Stawski L, Marden G, Iwamoto M, Trojanowska M. Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis. Am J Respir Cell Mol Biol. 2017;57(1):121–131. PMCID: PMC5516275
Matsuki M, Adachi Y, Ozawa Y, Kimura T, Hoshi T, Okamoto K, Tohyama O, Mitsuhashi K, Yamaguchi A, Matsui J, Funahashi Y. Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus. Cancer Sci. 2017 Apr;108(4):763–771. PMCID: PMC5406533
Yanagida K, Liu CH, Faraco G, Galvani S, Smith HK, Burg N, Anrather J, Sanchez T, Iadecola C, Hla T. Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1. PNAS. 2017 Apr 25;114(17):4531–4536. PMID: 28396408
Zaccagnino A, Managò A, Leanza L, Gontarewitz A, Linder B, Azzolini M, Biasutto L, Zoratti M, Peruzzo R, Legler K, Trauzold A, Kalthoff H, Szabo I. Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Oncotarget. 2017 Jun 13;8(24):38276–38293. PMCID: PMC5503532
Stout-Delgado HW, Cho SJ, Chu SG, Mitzel DN, Villalba J, El-Chemaly S, Ryter SW, Choi AMK, Rosas IO. Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation. Am J Respir Cell Mol Biol. 2016;55(2):252–263. PMCID: PMC4979364
Rovithi M, de Haas RR, Honeywell RJ, Poel D, Peters GJ, Griffioen AW, Verheul HMW. Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth. J Exp Clin Cancer Res. 2016 Sep 7;35(1):138. PMCID: PMC5013589
Rossi E, Gerges I, Tocchio A, Tamplenizza M, Aprile P, Recordati C, Martello F, Martin I, Milani P, Lenardi C. Biologically and mechanically driven design of an RGD-mimetic macroporous foam for adipose tissue engineering applications. Biomaterials. 2016;104:65–77. PMID: 27428768
Shami A, Knutsson A, Dunér P, Rauch U, Bengtsson E, Tengryd C, Murugesan V, Durbeej M, Gon?alves I, Nilsson J, Hultg?rdh-Nilsson A. Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice. Sci Rep. 2015 Sep 8;5:13904. PMCID: PMC4561962
Goumas FA, Holmer R, Egberts J-H, Gontarewicz A, Heneweer C, Geisen U, Hauser C, Mende M-M, Legler K, R?cken C, Becker T, Waetzig GH, Rose-John S, Kalthoff H. Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. Int J Cancer. 2015 Sep 1;137(5):1035–1046. PMID: 25604508
Yue GG-L, Lee JK-M, Kwok H-F, Cheng L, Wong EC-W, Jiang L, Yu H, Leung H-W, Wong Y-L, Leung P-C, Fung K-P, Lau CB-S. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite. Sci Rep. 2015 Jun 8;5:11149. PMCID: PMC4459151
Nowak-Sliwinska P, Weiss A, van Beijnum JR, Wong TJ, Kilarski WW, Szewczyk G, Verheul HMW, Sarna T, van den Bergh H, Griffioen AW. Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition. Cell Death Dis. 2015 Feb 12;6:e1641. PMCID: PMC4669819
Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, Kühl AA. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7(8):4557–4576. PMCID: PMC4152019
El-Gazzar A, Cai X, Reeves RS, Dai Z, Caballero-Benitez A, McDonald DL, Vazquez J, Gooley TA, Sale GE, Spies T, Groh V. Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells. Oncogene. 2014 Oct 9;33(41):4932–4940. PMCID: PMC3994187
Sun X, He S, Wara AKM, Icli B, Shvartz E, Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, Croce K, Feinberg MW. Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res. 2014 Jan 3;114(1):32–40. PMCID: PMC4051320
Becker MO, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, Witzenrath M, Kühl AA, Heidecke H, Ghofrani HA, Tiede H, Schermuly RT, Nickel N, Hoeper MM, Lukitsch I, Gollasch M, Kuebler WM, Bock S, Burmester GR, Dragun D, Riemekasten G. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med. 2014 Oct 1;190(7):808–817. PMID: 25181620
Copeland BT, Bowman MJ, Ashman LK. Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model. Mol Cancer Res. 2013 Jan;11(1):95–105. PMID: 23131993
Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NV. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett. 2013 Jul 10;335(1):41–51. PMCID: PMC3665739
Ferretti E, Montagna D, Di Carlo E, Cocco C, Ribatti D, Ognio E, Sorrentino C, Lisini D, Bertaina A, Locatelli F, Pistoia V, Airoldi I. Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. Leukemia. 2012 Feb;26(2):225–235. PMID: 21844875
Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, Girard J-P. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol. 2012 Apr 1;188(7):3488–3495. PMID: 22371395
Jiang J, Thyagarajan-Sahu A, Krchňák V, Jedinak A, Sandusky GE, Sliva D. NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo. PLoS ONE. 2012;7(3):e34283. PMCID: PMC3315582
Nishimura R, Wakabayashi M, Hata K, Matsubara T, Honma S, Wakisaka S, Kiyonari H, Shioi G, Yamaguchi A, Tsumaki N, Akiyama H, Yoneda T. Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J Biol Chem. 2012 Sep 28;287(40):33179–33190. PMCID: PMC3460424
Kramer-Marek G, Gijsen M, Kiesewetter DO, Bennett R, Roxanis I, Zielinski R, Kong A, Capala J. Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model. J Nucl Med. 2012 Apr;53(4):629–637. PMID: 22410461
Martin-Padura I, Marighetti P, Agliano A, Colombo F, Larzabal L, Redrado M, Bleau A-M, Prior C, Bertolini F, Calvo A. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts. Lab Invest. 2012 Jul;92(7):952–966. PMID: 22546866
H?lscher M, Silter M, Krull S, von Ahlen M, Hesse A, Schwartz P, Wielockx B, Breier G, Katschinski DM, Zieseniss A. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J Biol Chem. 2011 Apr 1;286(13):11185–11194. PMCID: PMC3064173
Kr?ger C, Vijayaraj P, Reuter U, Windoffer R, Simmons D, Heukamp L, Leube R, Magin TM. Placental vasculogenesis is regulated by keratin-mediated hyperoxia in murine decidual tissues. Am J Pathol. 2011 Apr;178(4):1578–1590. PMCID: PMC3078447
Agliano A, Martin-Padura I, Marighetti P, Gregato G, Calleri A, Prior C, Redrado M, Calvo A, Bertolini F. Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm. Clin Cancer Res. 2011 Oct 1;17(19):6163–6173. PMID: 21856771
Anania MC, Sensi M, Radaelli E, Miranda C, Vizioli MG, Pagliardini S, Favini E, Cleris L, Supino R, Formelli F, Borrello MG, Pierotti MA, Greco A. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. Oncogene. 2011 Jul 7;30(27):3011–3023. PMID: 21339735
Gramann M, Wendler O, Haeberle L, Schick B. Prominent collagen type VI expression in juvenile angiofibromas. Histochem Cell Biol. 2009 Jan;131(1):155–164. PMID: 18797915